📍 NEW YORK CITY, USA
LIVE
Pfizer shifts strategic priorities toward oncology and anti-obesity treatments as Covid demand wanes
Pfizer chief executive officer has articulated a decisive strategic transition for the pharmaceutical giant, shifting resources away from coronavirus countermeasures toward high-growth therapeutic areas including cancer ...